JMI LABS IS NOW PART OF LEARN MORE

Oritavancin Activity tested against Resistant Subsets of Gram-Positive Pathogens, Lead author: Jones RN, presented at 47th annual Infectious Diseases Society of America (IDSA), October 29 – November 1, 2009, Philadelphia, PA

View publication